Improving treatment decisions for oropharyngeal cancer using advanced imaging techniques
Precision imaging for risk stratification and personalized therapy of oropharyngeal cancer
This study is looking to improve how we treat oropharyngeal cancer by using advanced imaging to better understand the disease and figure out the best treatment for each patient, especially for those with HPV-positive and HPV-negative cancers, so that we can minimize side effects and make the treatment more effective.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11058455 on NIH RePORTER |
What this research studies
This research focuses on enhancing the treatment of oropharyngeal cancer (OPC) by using advanced imaging techniques to better understand the disease's progression. It aims to develop new methods for predicting how individual patients will respond to treatment, particularly distinguishing between those with HPV-positive and HPV-negative cancers. By analyzing detailed CT imaging and integrating it with clinical data, the study seeks to create personalized treatment plans that reduce unnecessary toxicity from standard therapies. Patients will be evaluated based on their cancer stage and smoking history to tailor their treatment effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with oropharyngeal cancer, particularly those with HPV-positive disease.
Not a fit: Patients with other types of cancers or those who do not have oropharyngeal cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and less toxic treatment options for patients with oropharyngeal cancer.
How similar studies have performed: Previous research has shown promise in using imaging techniques for cancer treatment personalization, indicating that this approach could be effective.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Li, Ruijiang — Stanford University
- Study coordinator: Li, Ruijiang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.